Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma
Keywords: IgG; immunoglobulin G; mAb; monoclonal antibody; MRP; multidrug resistance protein; PDAC; pancreatic ductal adenocarcinoma; SCID; severe combined immunodeficiency; SD; standard deviation; TUNEL; TdT-mediated dUTP nick end labelling; VEGF; Vascular Endothe